No Data
Retail Investors Are HitGen Inc.'s (SHSE:688222) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥595m Last Week
Hitgen Inc. releases the 2024 annual report: the Global Strategy layout has shown significant results, and multiple technology platforms collaboratively drive high-quality growth.
Chengdu, April 26, 2025 / PR Newswire / -- On the evening of April 25, Hitgen Inc. (Stock Code: 688222.SH, hereinafter referred to as "Hitgen" or "the Company"), a listed company on the Star of the Shanghai Exchange, announced its annual report for 2024 and its quarterly report for the first quarter of 2025 (hereinafter referred to as "annual report" and "quarterly report"). In 2024, the company achieved a revenue of 0.427 billion yuan, a year-on-year increase of 14.99%, with both domestic and overseas markets experiencing revenue growth, maintaining competitiveness and continuous growth in the global market.
Chengdu Pilot Drug Development Co., Ltd. 2024 Annual Report
Summary of the 2024 Annual Report of Chengdu Pilot Drug Development Co., Ltd.
Chengdu Pilot Drug Development Co., Ltd. Report for the first quarter of 2025
The Five-year Shareholder Returns and Company Earnings Persist Lower as HitGen (SHSE:688222) Stock Falls a Further 14% in Past Week
Time To Worry? Analysts Are Downgrading Their HitGen Inc. (SHSE:688222) Outlook